These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15645693)

  • 1. An open label 12-month pilot trial on the effects of the aromatase inhibitor anastrozole in growth hormone (GH)-treated GH deficient adolescent boys.
    Mauras N; Welch S; Rini A; Klein KO
    J Pediatr Endocrinol Metab; 2004 Dec; 17(12):1597-606. PubMed ID: 15645693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
    Mauras N; Gonzalez de Pijem L; Hsiang HY; Desrosiers P; Rapaport R; Schwartz ID; Klein KO; Singh RJ; Miyamoto A; Bishop K
    J Clin Endocrinol Metab; 2008 Mar; 93(3):823-31. PubMed ID: 18165285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
    Mauras N; Ross JL; Gagliardi P; Yu YM; Hossain J; Permuy J; Damaso L; Merinbaum D; Singh RJ; Gaete X; Mericq V
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4984-4993. PubMed ID: 27710241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
    Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with GH and anastrozole in a pubertal boy with Cushing's disease and postsurgical GH deficiency.
    Boronat M; Marrero D; López-Plasencia Y; Nóvoa Y; García-Delgado Y; Nóvoa FJ
    Eur J Endocrinol; 2012 Jun; 166(6):1101-5. PubMed ID: 22447814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
    Hero M; Norjavaara E; Dunkel L
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome analysis of aromatase inhibitor therapy to increase adult height in males with predicted short adult stature and/or rapid pubertal progress: a retrospective chart review.
    Shams K; Cameo T; Fennoy I; Hassoun AA; Lerner SE; Aranoff GS; Sopher AB; Yang C; McMahon DJ; Oberfield SE
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):725-30. PubMed ID: 24756052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.
    Papadimitriou DT; Dermitzaki E; Papagianni M; Papaioannou G; Papaevangelou V; Papadimitriou A
    J Endocrinol Invest; 2016 Apr; 39(4):439-46. PubMed ID: 26507391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia.
    Mauras N; Bishop K; Merinbaum D; Emeribe U; Agbo F; Lowe E
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2975-8. PubMed ID: 19470631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aromatase inhibition vs. testosterone in older men with low testosterone: randomized-controlled trial.
    Dias JP; Melvin D; Simonsick EM; Carlson O; Shardell MD; Ferrucci L; Chia CW; Basaria S; Egan JM
    Andrology; 2016 Jan; 4(1):33-40. PubMed ID: 26588809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen suppression in males: metabolic effects.
    Mauras N; O'Brien KO; Klein KO; Hayes V
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2370-7. PubMed ID: 10902781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor.
    Wickman S; Saukkonen T; Dunkel L
    Eur J Endocrinol; 2002 Mar; 146(3):339-46. PubMed ID: 11888840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
    Leder BZ; Finkelstein JS
    Osteoporos Int; 2005 Dec; 16(12):1487-94. PubMed ID: 15856361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel treatment of short stature with aromatase inhibitors.
    Dunkel L; Wickman S
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):345-56. PubMed ID: 14623531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S; Kajantie E; Dunkel L
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
    Halper A; Sanchez B; Hodges JS; Dengel DR; Petryk A; Sarafoglou K
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):124-130. PubMed ID: 31070802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature.
    Hero M; Mäkitie O; Kröger H; Nousiainen E; Toiviainen-Salo S; Dunkel L
    Horm Res; 2009; 71(5):290-7. PubMed ID: 19339794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.
    Lenz AM; Shulman D; Eugster EA; Rahhal S; Fuqua JS; Pescovitz OH; Lewis KA
    Pediatrics; 2010 Sep; 126(3):e728-33. PubMed ID: 20713483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.